62.2 F
New York
Friday, September 24, 2021

Glaukos Corporation [NYSE: GKOS] Inks Agreement with Santen Pharmaceutical

Must read

XPeng [NYSE: XPEV] Backed HT Aero Launch Flying Vehicle City Usage Scenarios

XPeng Inc. disclosed that HT Aero has launched future urban usage scenarios for its fifth-generation flying vehicle XPeng X2 (X2). It includes independent...

Metrospaces Choose Cryptobucks as Preferred Cryptocurrency Partner

Metrospaces disclosed that it has selected Cryptobucks as its preferred cryptocurrency partner. It has inked an agreement to consolidate Cryptobucks into all of its...

Novartis [NYSE: NVS] Announces Acquisition of Arctos Medical

Novartis AG disclosed that it has acquired Arctos Medical. This purchase decision will add a pre-clinical optogenetics-based AAV gene therapy program and Arctos’...

Mastercard [NYSE: MA] Announces Launch of Sustainability Innovation Lab

Mastercard Incorporated has introduced a new sustainability innovation lab. The firm disclosed that its new lab will lead the further development of the...

Glaukos Corporation [NYSE: GKOS] declared that it has signed a development and commercialization license agreement with Santen Pharmaceutical Co., Ltd. (Santen) for the PRESERFLO MicroShunt. This new agreement is the substitute for earlier partnership and distribution agreements between the two parties.

As per the agreement, Glaukos receive special commercialization rights for the MicroShunt in New Zealand, Canada, Brazil, Mexico, the US, and Australia the rest of Latin America. Furthermore, this new agreement also provides GKOS full control over all development activities for the MicroShunt in these same areas. It involves overall clinical development and regulatory affairs activities in the US after a transition period.

Additionally, Santen also lodged a premarket approval (PMA) application to the U.S. FDA in June 2020, and negotiations with the FDA are underway. Santen will continue to produce and supply the MicroShunt for the Glaukos areas and lead development and marketing activities somewhere else. The firm has not yet revealed the financial terms of the agreement.

The PRESERFLO MicroShunt is an ab-externo, a drainage system. It assists in the drain of eye fluid. It also lessens IOP in sufferers with primary open-angle glaucoma whose IOP is not controlled when using maximum tolerated glaucoma medications or where glaucoma progression warrants surgery. To reduce glaucoma and vision loss only thing which works is to reduce IOP.

More articles

Latest article

ReneSola [NYSE: SOL] and Eiffel’s Joint Venture Buys Its First 200 MW Project Portfolio

ReneSola Ltd disclosed that European Solar Energy Development JV has finalized the purchase of its first batch of solar projects with a combined...

Square [NYSE: SQ] Launch its Early Access Program in Spain

Square, Inc. which has earned a reputation as a software, payments, and hardware solution firm for all types of businesses disclosed that it...

Ideanomics [NASDAQ: IDEX] Decides to Increase Stake in Energica

Ideanomics, Inc. disclosed that it has decided to ink an agreement with Energica Company. As per the agreement, the firm has decided to...

L3Harris’ [NYSE: LHX] Robot Chosen to Protect US Air Force Bases Around the Globe

L3Harris Technologies, Inc. disclosed that it has received a huge contract from US Air Force. The firm revealed that its robot will now...

Tower Semiconductor [NASDAQ: TSEM] Introduces Breakthrough LiDAR Technology

Tower Semiconductor Ltd. has introduced a breakthrough development of LiDAR IC technology created for sophisticated driver-assistance systems (ADAS) and ultimately self-driving cars. The...

KKR [NYSE: KKR] Decides to Divest Riata Corporate Park

KKR & Co. Inc. has disclosed that it has decided to divest the Riata Corporate Park. Riata Corporate Park is an eight-building, 688,100...

3D Systems [NYSE: DDD] Unveil VisiJet Wax Jewel Red

3D Systems Corporation has launched the VisiJet Wax Jewel Red. It will allow jewelry makers to design and create more sophisticated, lasting patterns....

Xerox [NYSE: XRX] Announces Transfer of Stock Exchange Listing to Nasdaq from NYSE

Xerox Holdings Corporation has made an important announcement regarding its listing on Stock Exchange. The firm has revealed that it has decided to...